These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26549849)
21. Nanog, Oct4 and Tet1 interplay in establishing pluripotency. Olariu V; Lövkvist C; Sneppen K Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218 [TBL] [Abstract][Full Text] [Related]
22. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells. Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724 [TBL] [Abstract][Full Text] [Related]
23. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells. Poursani EM; Mehravar M; Soltani BM; Mowla SJ Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916 [TBL] [Abstract][Full Text] [Related]
24. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. Zhang X; Zhang J; Wang T; Esteban MA; Pei D J Biol Chem; 2008 Dec; 283(51):35825-33. PubMed ID: 18957414 [TBL] [Abstract][Full Text] [Related]
25. The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal. Liu Y; Kim H; Liang J; Lu W; Ouyang B; Liu D; Songyang Z J Biol Chem; 2014 Feb; 289(8):4778-86. PubMed ID: 24347171 [TBL] [Abstract][Full Text] [Related]
26. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines. Western P; Maldonado-Saldivia J; van den Bergen J; Hajkova P; Saitou M; Barton S; Surani MA Stem Cells; 2005; 23(10):1436-42. PubMed ID: 16166252 [TBL] [Abstract][Full Text] [Related]
27. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells. Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534 [TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of pluripotency and reprogramming. Na J; Plews J; Li J; Wongtrakoongate P; Tuuri T; Feki A; Andrews PW; Unger C Stem Cell Res Ther; 2010 Oct; 1(4):33. PubMed ID: 20974014 [TBL] [Abstract][Full Text] [Related]
31. Regulation of embryonic stem cell pluripotency by heat shock protein 90. Bradley E; Bieberich E; Mivechi NF; Tangpisuthipongsa D; Wang G Stem Cells; 2012 Aug; 30(8):1624-33. PubMed ID: 22696450 [TBL] [Abstract][Full Text] [Related]
32. LSD1-mediated demethylation of OCT4 safeguards pluripotent stem cells by maintaining the transcription of PORE-motif-containing genes. Dan S; Song Y; Duan X; Pan X; Chen C; She S; Su T; Li J; Chen X; Zhou Y; Chen W; Zhang X; Pan X; Wang YJ; Kang B Sci Rep; 2021 May; 11(1):10285. PubMed ID: 33986438 [TBL] [Abstract][Full Text] [Related]
33. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Jang H; Kim TW; Yoon S; Choi SY; Kang TW; Kim SY; Kwon YW; Cho EJ; Youn HD Cell Stem Cell; 2012 Jul; 11(1):62-74. PubMed ID: 22608532 [TBL] [Abstract][Full Text] [Related]
34. High content screening for modulators of cardiac differentiation in human pluripotent stem cells. Spiering S; Davidovics H; Bushway PJ; Mercola M; Willems E Methods Mol Biol; 2015; 1263():43-61. PubMed ID: 25618335 [TBL] [Abstract][Full Text] [Related]
35. Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells. Alva JA; Lee GE; Escobar EE; Pyle AD Stem Cells; 2011 Dec; 29(12):1952-62. PubMed ID: 21948699 [TBL] [Abstract][Full Text] [Related]
36. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kaupisch A; Kane NM; Baillie GS; Baker AH; Milligan G; Houslay MD; Mountford JC Biochem J; 2010 Dec; 432(3):575-84. PubMed ID: 20923411 [TBL] [Abstract][Full Text] [Related]
37. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Theunissen TW; Powell BE; Wang H; Mitalipova M; Faddah DA; Reddy J; Fan ZP; Maetzel D; Ganz K; Shi L; Lungjangwa T; Imsoonthornruksa S; Stelzer Y; Rangarajan S; D'Alessio A; Zhang J; Gao Q; Dawlaty MM; Young RA; Gray NS; Jaenisch R Cell Stem Cell; 2014 Oct; 15(4):471-487. PubMed ID: 25090446 [TBL] [Abstract][Full Text] [Related]
38. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers. AlAbdi L; Saha D; He M; Dar MS; Utturkar SM; Sudyanti PA; McCune S; Spears BH; Breedlove JA; Lanman NA; Gowher H Cell Rep; 2020 Feb; 30(5):1478-1490.e6. PubMed ID: 32023463 [TBL] [Abstract][Full Text] [Related]
39. A competitive protein interaction network buffers Oct4-mediated differentiation to promote pluripotency in embryonic stem cells. Muñoz Descalzo S; Rué P; Faunes F; Hayward P; Jakt LM; Balayo T; Garcia-Ojalvo J; Martinez Arias A Mol Syst Biol; 2013 Oct; 9():694. PubMed ID: 24104477 [TBL] [Abstract][Full Text] [Related]
40. [OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells]. Medvedev SP; Shevchenko AI; Mazurok NA; Zakiian SM Genetika; 2008 Dec; 44(12):1589-608. PubMed ID: 19178078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]